23 Podcast Episodes
685: Cathal Friel of Poolbeg Pharma discusses results of the proposal to purchase shares from distribution in specie shareholders
685: Cathal Friel of Poolbeg Pharma discusses results of the proposal to purchase shares from distribution in specie shareholders
Cathal Friel Chairman of Poolbeg Pharma #POLB discusses the results of the proposal to purchase shares from distribution... Read more
27 Apr 2022
•
4mins
660: Cathal Friel of Poolbeg Pharma: Specie share purchase should increase liquidity & maximise shareholder value
660: Cathal Friel of Poolbeg Pharma: Specie share purchase should increase liquidity & maximise shareholder value
Cathal Friel, Chairman of Poolbeg Pharma #POLB explains how the proposal to purchase shares from distribution off specie... Read more
11 Apr 2022
•
4mins
651: Cathal Friel & Jeremy Skillington of Poolbeg Pharma explain why they have listed on the OTCQB Venture Market in the US
651: Cathal Friel & Jeremy Skillington of Poolbeg Pharma explain why they have listed on the OTCQB Venture Market in the US
Cathal Friel, Chairman & Jeremy Skillington, CEO of Poolbeg Pharma #POLB explains why the shares have started tradin... Read more
4 Apr 2022
•
7mins
596: Cathal Friel & Mo Khan of Open Orphan expect 2021 to be EBITDA positive on revenues of £40m
596: Cathal Friel & Mo Khan of Open Orphan expect 2021 to be EBITDA positive on revenues of £40m
Cathal Friel, Executive Chairman & Mo Khan, CEO of Open Orphan #ORPH discuss their trading update where they expect ... Read more
9 Mar 2022
•
8mins
586: Cathal Friel & Jeremy Skillington of Poolbeg Pharma discuss the significant progress since IPO & growing pipeline
586: Cathal Friel & Jeremy Skillington of Poolbeg Pharma discuss the significant progress since IPO & growing pipeline
Cathal Friel, Chairman & Jeremy Skillington CEO of Poolbeg Pharma #POLB discuss the significant progress since IPO &... Read more
3 Mar 2022
•
8mins
574: Cathal Friel & Mo Khan, the newly appointed CEO of Open Orphan, discuss the new board structure
574: Cathal Friel & Mo Khan, the newly appointed CEO of Open Orphan, discuss the new board structure
Cathal Friel, Executive Chairman & Mo Khan, the newly appointed CEO of Open Orphan #ORPH discuss the new board struc... Read more
24 Feb 2022
•
3mins
543: Cathal Friel of Open Orphan discusses the results from the world's first COVID-19 Characterisation Study
543: Cathal Friel of Open Orphan discusses the results from the world's first COVID-19 Characterisation Study
Cathal Friel, Executive Chairman of Open Orphan #ORPH discusses the results from the world's first COVID-19 Characterisa... Read more
2 Feb 2022
•
8mins
346: Cathal Friel of Open Orphan discusses their 242% revenue growth in H1 & £5.7m New Contract Win
346: Cathal Friel of Open Orphan discusses their 242% revenue growth in H1 & £5.7m New Contract Win
Cathal Friel, Executive Chairman of Open Orphan #ORPH discusses their 242% revenue growth in H1 & £5.7m New Contract... Read more
20 Sep 2021
•
8mins
306: Cathal Friel, Executive Chairman of Open Orphan talks about their £8.1m contract with a Major Global Pharma Company
306: Cathal Friel, Executive Chairman of Open Orphan talks about their £8.1m contract with a Major Global Pharma Company
Cathal Friel, Executive Chairman of Open Orphan #ORPH talks about their £8.1m contract with a Major Global Pharma Compan... Read more
24 Aug 2021
•
8mins
31: Cathal Friel of Open Orphan discusses why he's made a substantial share purchase
31: Cathal Friel of Open Orphan discusses why he's made a substantial share purchase
Cathal Friel, Executive Chairman of Open Orphan #ORPH discusses the plethora of news they've released today including wh... Read more
14 Jul 2021
•
8mins